Description
Product details
MYCOPLASM S 360 Mycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens. Uses of Mycophenolate Sodium 360 mg Mycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues. The drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes. Key Benefits of Mycophenolate Sodium 360 mg Mycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation. Enhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates. Improved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions. Flexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy. Pediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety. Cost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations. Patients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment. Side Effects of Mycophenolate Sodium 360 mg While highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow. Common Side Effects Gastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users. Headache, insomnia, and tremor, often mild and transient. Infections such as urinary tract or respiratory, due to moderated immunity. Hypertension or peripheral edema, manageable with supportive care. Leukopenia or anemia, requiring periodic blood counts. Serious Side Effects Severe myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks. Progressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation. Gastrointestinal perforation or bleeding, especially in at-risk patients. Increased malignancy risk, including lymphoma or skin cancers, over long-term use. Hypersensitivity reactions like rash or anaphylaxis. Regular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly. Mechanism of Action Mycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production. MPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form. Dosage and Administration Guidelines Standard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating. Precautions and Warnings Avoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited. Conclusion Mycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely. Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 ORDER Now: https://www.sterisonline.com/product/mycoplasm-s-360-133670
![Bisoprolol 1.25mg is the smallest tablet strength of bisoprolol, a heart-selective beta-1 blocker. Doctors usually prescribe it to start treatment or to build up the dose gradually in people with high blood pressure, chronic stable heart failure, or fast heart rhythms. It suits older adults, people with mild heart failure, and anyone who reacts strongly to beta-blockers. The medicine slows the heartbeat and eases the force of each contraction, so the heart works less hard. BISOGARD 1.25 from Steris Healthcare Pvt. Ltd. comes in a strip pack of 15 tablets. It is a Schedule H medicine, so it must only be started, changed, or stopped on a doctor's advice.
Product Snapshot
Brand: BISOGARD 1.25
Manufacturer/Marketer: Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company in India
Active ingredient: Bisoprolol Fumarate 1.25mg
Form: Tablet
Pack size: 15 tablets
Drug class: Cardioselective beta-1 blocker
Legal status: Schedule H (valid prescription required)
Availability: Through Steris Healthcare's authorized pharmacies and its B2B PCD franchise network across India
What Is Bisoprolol 1.25mg?
If your doctor has just prescribed bisoprolol 1.25mg, you have been given the lowest dose on purpose. Bisoprolol is a cardioselective beta-1 blocker, meaning it acts mostly on receptors in the heart and has much less effect on the lungs and blood vessels. This is a major reason it is preferred over older, non-selective beta-blockers, especially for people who also have a mild breathing problem.
The 1.25mg tablet is not a “light” medicine for mild illness. It is a carefully chosen entry point. In heart failure, a weakened heart can struggle if its rate or pressure drops too quickly, so cardiologists follow a “start low, go slow” approach. Treatment begins at 1.25mg, the response is watched for one to two weeks, and the dose is raised step by step (commonly 2.5mg, 3.75mg, 5mg, 7.5mg, and up to 10mg) as the heart adapts. That is why BISOGARD 1.25 is often the first tablet a newly diagnosed heart failure patient takes.
What Is Bisoprolol 1.25mg Used For?
Doctors commonly prescribe this strength for:
Chronic heart failure (HFrEF): as the first step of dose titration in patients with a reduced ejection fraction, alongside ACE inhibitors/ARBs and diuretics
High blood pressure: especially in older adults, people with low body weight, and those who are sensitive to blood-pressure-lowering drugs
Stable angina: to reduce the heart's oxygen demand and relieve chest discomfort
After a heart attack: in selected patients, under a cardiologist's care
Heart rate control in some arrhythmias: sometimes used off-label at a low dose to gently bring down a fast heart rate
At 1.25mg, bisoprolol is seldom meant as the long-term sole treatment for high blood pressure in an otherwise healthy adult. It is usually the first rung of a titration ladder, or a steady maintenance dose for patients who are unusually beta-blocker sensitive (older age, low body weight, or borderline low pressure or pulse).
How Does Bisoprolol Work?
Bisoprolol selectively blocks beta-1 adrenergic receptors, which are packed mainly into heart muscle. This leads to several effects:
Slower heart rate: the heart has more time to fill and rest between beats
Gentler contractions: the heart muscle needs less oxygen and energy
Less renin from the kidneys: this helps blood pressure fall gradually over time
Lower overall cardiac workload: a real advantage for a heart that already struggles to pump well, as in heart failure
Key Benefits of BISOGARD 1.25
A gentle starting dose, well suited to careful titration in frail or elderly patients
Heart-focused action, with less effect on the lungs and peripheral blood vessels than non-selective beta-blockers
Once-daily dosing, which makes it easier to stay on treatment
A guideline-recommended beta-blocker for HFrEF with well-established outcomes data [Reviewer note: insert specific outcome statistics/trial citation pending medical sign-off]
Made by Steris Healthcare Pvt. Ltd. under WHO-GMP and ISO-certified standards
Dosage Guidance
Usual starting dose (heart failure): 1.25mg once a day, preferably in the morning
Dose increases: typically every 1–2 weeks (2.5mg, 3.75mg, 5mg, 7.5mg, up to a maximum of 10mg daily), depending on how well you tolerate it and on your pulse and blood pressure
High blood pressure (sensitive patients): 1.25mg to 5mg once daily, as set by your doctor
How to take it: at the same time every day, with or without food, swallowed whole with water
If you miss a dose: take it when you remember, unless the next dose is almost due. Never take a double dose.
Never stop suddenly: abrupt withdrawal can cause a rebound rise in heart rate, blood pressure, or chest pain. The dose must be reduced gradually under medical supervision.
Is It Better to Take Bisoprolol in the Morning or at Night?
Most doctors advise a morning dose. Bisoprolol lowers pulse and blood pressure, and taking it early matches its action to your daytime activity. A night-time dose could add to the body's natural overnight dip in blood pressure and raise the chance of dizziness when getting up in the dark. Some people who feel tired during the day are told by their doctor to switch to the evening. Do not change your dosing time without your doctor's approval.
Side Effects of Bisoprolol 1.25mg
Common side effects
Tiredness or fatigue
Dizziness or light-headedness, especially on standing quickly
Cold hands or feet
Slow pulse (bradycardia)
Headache
Mild stomach upset (nausea, loose stools)
Disturbed sleep
Serious side effects (get medical help promptly)
Very slow heartbeat or fainting
Increasing breathlessness or swollen legs/ankles, which may mean heart failure is worsening
Allergic reaction: rash, swelling of the face or throat, trouble breathing
Cold, numb, or bluish fingers and toes
Wheezing or new breathing difficulty, particularly in people with asthma or COPD
Mood changes, low mood, or confusion
What Are the Bad Side Effects of Bisoprolol?
The effects that need urgent attention are a dangerously slow pulse, fainting, signs of worsening heart failure (swelling, breathlessness), severe allergic reactions, and airway tightening in people with lung disease. These are uncommon at the 1.25mg dose, but anyone who notices them should seek medical help right away. [Reviewer note: specific incidence rates pending clinical/medical sign-off]
Substitutes & Comparable Beta-Blockers
Molecule Selectivity Typical Use Case
Bisoprolol Highly cardioselective Heart failure titration, hypertension
Metoprolol Succinate ER Cardioselective Hypertension, angina, heart failure
Atenolol Cardioselective (older agent) Hypertension
Carvedilol Non-selective with alpha-blocking action Heart failure (adds vasodilation)
Propranolol Non-selective Migraine prevention, anxiety-related fast heartbeat, essential tremor
Precautions & Who Should Avoid Bisoprolol
Not suitable for people with severe bradycardia, certain forms of heart block (unless a pacemaker is fitted), unstable or acutely decompensated heart failure, or severe uncontrolled asthma
Use carefully in diabetes, because beta-blockers can hide the warning signs of low blood sugar
Take care in peripheral vascular disease, as cold extremities or leg pain on walking may worsen
Never stop it abruptly; always taper under a doctor's guidance
Tell your doctor about every medicine you use, especially other blood-pressure drugs, calcium channel blockers, and certain antiarrhythmics
In pregnancy and breastfeeding, use only if your doctor advises it after weighing benefits and risks
Is Bisoprolol Safe for Kidneys?
The body clears bisoprolol through both the liver and the kidneys in roughly equal measure. It is generally considered safe for people with normal or mildly reduced kidney function. When kidney impairment is significant, drug levels in the blood can rise, so your doctor may lower the dose or monitor you more closely. Always tell your prescriber about any kidney disease before starting.
Is Bisoprolol a High-Risk Medication?
Bisoprolol is not a narrow therapeutic index drug like tacrolimus or warfarin, where small dose differences matter greatly. Even so, it needs supervised use because it directly affects heart rate and blood pressure. The main dangers are stopping it suddenly, which can set off rebound cardiac events, and using it with certain existing rhythm disorders. Taken as prescribed and checked regularly, it has a long and reassuring safety record.
Does 1.25mg Bisoprolol Lower Blood Pressure?
Yes. Even the smallest dose measurably reduces heart rate and blood pressure by lightening the heart's workload and reducing renin-driven narrowing of blood vessels. At this strength the effect on blood pressure is fairly mild, which is exactly why it is a safe place to begin, especially for older adults or people starting heart failure treatment. The dose is then raised gradually to reach full benefit.
Frequently Asked Questions
1. What is 1.25 mg of bisoprolol used for?
Mainly as a low starting dose when building up treatment for chronic heart failure, and for high blood pressure in people who are very sensitive to beta-blockers, such as older adults.
2. What are the bad side effects of bisoprolol?
The more serious ones are a very slow pulse, fainting, worsening heart failure signs (swelling, breathlessness), severe allergy, and breathing trouble in people with lung conditions.
3. What are the common side effects of bisoprolol fumarate 1.25 mg tablets?
Tiredness, dizziness, cold hands and feet, mild headache, and a slightly slower pulse.
4. Is it better to take bisoprolol in the morning or at night?
Morning is usually preferred so its effect fits daytime activity, though your doctor may suggest evenings in some cases.
5. What is the cost of bisoprolol?
Price depends on strength, pack size, and brand. Use the “Check Price” option above for current BISOGARD 1.25 pricing from Steris Healthcare.
6. Does 1.25 mg bisoprolol lower blood pressure?
Yes, though only modestly at this dose. The dose is often stepped up over time.
7. Is bisoprolol safe for kidneys?
Generally yes for normal or mildly reduced kidney function. People with significant kidney impairment need dose adjustment and monitoring.
8. Is bisoprolol a high-risk medication?
It is not a narrow therapeutic index drug, but it must never be stopped suddenly and should be used under medical supervision because of its direct effect on the heart.
9. Can I take bisoprolol 1.25mg for the rest of my life?
Many people with chronic heart failure or hypertension do take bisoprolol long term, but the dose usually rises as tolerated. Your doctor should review it regularly.
10. What happens if I miss a dose of bisoprolol?
Take it when you remember, unless the next dose is nearly due. In that case skip the missed one. Never take two together.
11. Can bisoprolol 1.25mg cause weight gain?
It is not commonly reported at this dose. Fluid retention linked to heart failure itself should be reported to your doctor.
12. Is bisoprolol safe for diabetic patients?
It can be used, with care, because beta-blockers may hide warning signs of low blood sugar such as a racing heartbeat.
13. Can I stop taking bisoprolol suddenly if I feel fine?
No. Stopping abruptly can cause a rebound rise in heart rate, blood pressure, or chest pain. Reduce the dose gradually under medical guidance.
14. Does bisoprolol interact with other blood pressure medicines?
Yes. Combining it with other drugs that lower heart rate or pressure (such as calcium channel blockers) can cause a very low pulse or pressure. Tell your doctor about all your medicines.
15. Is BISOGARD 1.25 available without a prescription?
No. Bisoprolol is a Schedule H medicine in India and needs a valid prescription.
16. How long does it take for bisoprolol 1.25mg to start working?
Some effect on heart rate appears within hours, but the full benefit for blood pressure or heart failure symptoms builds over several weeks of regular use.
17. Can pregnant women take bisoprolol?
Only if clearly necessary and prescribed by a doctor, as it may affect the baby's heart rate and growth.](https://productimages.withfloats.com/tile/6abe4474c205678e0b16a23a.png)
